RE:RE:RE:RE:RE:So now they have a significant trial in Turkey Thanks for your input Insightful1. I'm still hanging in here, in fact added a bit more yesterday. Wish that the ceo, cfo would also open positions. Hopefully soon, maybe it's a blackout with the quarter about to be released in the next two weeks.
Needless to say, since I've been here, about four years now, this has been one of the most frustrating stocks I've owned, and I've owned a lot. I have traded out twice and done well and should have stayed away until now...or a few months from now.?
The market is not giving any value to Mdx as it still needs to prove out the commercialization aspect. Minimal revenues, big losses, shareholder dilution - not very attractive. Interest rates will be rising. Micro cap growth stocks that are not cash flow positive could easily get hammered in a rising interest rate environment.
I do like seeing recent news: Netherlands, Empower in Canada, and they Empower is focusing on the USA in 2022, an Italy pilot, the Turkey pilot, and I believe that more will follow.
So, this remains a high risk, speculative investment that is on the slow track to, fingers crossed, commercialization success, including, fingers crossed, government re-imbursement. Seems to now be a 'tuck it away' stock and come back in a year to see where we are at. Temper your short term expectations for revenue. This will take time. GLTA.
Appreciate seeing you buy in the open market Mr. Hennigar. Sylvain, Lesley - we are waiting!